project id: TCGA-SKCM; case submitter id: TCGA-DA-A1I2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.1; age at index: 45; days to birth: -16701; days to death: 5370; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1951; age at diagnosis: 16701; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage III; ajcc pathologic t: T4b; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 5088.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1996; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 5332; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-DA-A1I2-06A-21; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;